Recent Dechra Pharmaceuticals News

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

I’d buy the dip in share prices as there are bargains to be had right now

There are great opportunities when share prices are falling and I'm looking for the best way to buy the dip…

Read more »

Investing Articles

FTSE 100 reshuffle: time to buy this hot growth stock?

This growth stock's promotion to the FTSE 100 (INDEXFTSE:UKX) looks nailed on. So, are the shares still a buy? Paul…

Read more »

Investing Articles

No savings at 40? I’d buy these 2 fast-growing FTSE 100 stocks to top up the State Pension

These two stocks offer growth today and protection in case of a market correction, in my opinion.

Read more »

Investing Articles

I tipped these 2 FTSE 250 stocks to outperform in 2019. Next year looks promising too

Harvey Jones says these FTSE 250 (INDEXFTSE:UKX) have shown their worth in 2019.

Read more »

Investing Articles

£6k to invest? These three growth champions are my top buys for 2020!

These growth champions dominate their respective markets and should continue to beat them for many years to come, argues Rupert…

Read more »

Investing Articles

Expensive but exceptional! 3 FTSE 250 growth shares that could help you to retire early

These FTSE 100 (INDEXFTSE: UKX) stocks may be expensive but they're worth every penny, argues Royston Wild.

Read more »

Investing Articles

Want to get rich? 3 FTSE 250 growth stocks that I’d buy and hold for the next 10 years

These growth giants from the FTSE 250 (INDEXFTSE: MCX) look set to thrive through the next 10 years at least,…

Read more »

Investing Articles

I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year.

Read more »

Investing Articles

2 FTSE 250 dividend stocks I’d buy and hold for 25 years

Royston Wild zeroes in on two terrific FTSE 250 (INDEXFTSE: MCX) income heroes that could make you richer.

Read more »

Investing Articles

GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now

Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm.

Read more »

Investing Articles

3 of the best growth stocks of 2018 (so far)

Royston Wild runs the rule over three stocks whose share prices have detonated in 2018. Can they keep climbing?

Read more »

Investing Articles

One super growth stock I’d buy ahead of SXX shares

Edward Sheldon explains why he won't be buying shares of Sirius Minerals plc (LON: SXX).

Read more »

Investing Articles

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune.

Read more »

Investing Articles

Does Halma plc’s double-digit growth make it the steal of the century?

Halma plc (LON: HLMA) has seen its earnings soar, and here's another that's done even better.

Read more »

Investing Articles

Looking to invest £2,000? Here are 2 pharma stocks I’d buy today

Harvey Jones says these two pharmaceutical stocks have something to please both momentum and contrarian investors.

Read more »

Investing Articles

2 no-brainer stocks I’d buy in pharma

Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth.

Read more »

Investing Articles

2 opportunities to beat the FTSE 100 which won’t last forever

These two stocks could help you to generate higher returns than the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

2 pharma stocks that could make you a millionaire

The FTSE 100 isn’t the last word for great pharmaceutical stocks. Here, Royston Wild looks at two medical marvels outside…

Read more »

Investing Articles

A growth-plus-dividend stock I’d buy ahead of Vodafone Group plc

Vodafone Group plc (LON:VOD) offers big dividends, but here's a smaller stock that could be a better buy.

Read more »

Investing Articles

2 stocks that could make you rich

Bilaal Mohamed identifies two London-listed firms with spectacular growth potential.

Read more »

Investing Articles

This FTSE 250 dog might be a stonking contrarian pick

Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock.

Read more »

Investing Articles

2 surprising growth stocks that could help you retire early

These two shares may offer higher growth rates than expected.

Read more »

Investing Articles

These great growth stocks have much further to go

Royston Wild looks at two stocks with hot earnings prospects.

Read more »

Investing Articles

One growth stock I’d buy — and one I’d sell — right now

Royston Wild discusses two growth stocks with very different near-term outlooks.

Read more »

Investing Articles

Enjoy double-digit earnings growth with these FTSE 250 stars

Royston Wild looks at three FTSE 250 (INDEXFTSE: MCX) stocks with spectacular earnings potential.

Read more »

Investing Articles

Why I’m avoiding these exciting growth shares right now

Bilaal Mohamed explains why investors should wait before buying these growth stocks.

Read more »

Investing Articles

Should you make room for Pets At Home Group plc after today’s update?

The market may not like today's update but Paul Summers thinks Pets At Home Group plc (LON:PETS) is a sound…

Read more »

Investing Articles

Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock?

Read more »

Investing Articles

4 growth stocks to put on your 2017 shopping list

Royston Wild runs the rule over some of London’s hottest growth stocks.

Read more »

Investing Articles

Could these top-performing stocks be about to collapse?

Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains.

Read more »

Investing Articles

2 shining pharmaceuticals stars to challenge the big guns?

Can these smaller upstarts beat the champions at their own game?

Read more »

Investing Articles

Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

4 perfect stocks for ‘Brexit Britain’!

Royston Wild reveals a cluster of stocks waiting to deliver plump shareholder returns.

Read more »

Investing Articles

Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc ‘buys’ after today’s updates?

Should you pile-in to these three stocks right now? RhythmOne plc (LON: RTHM), Dechra Pharmaceuticals plc (LON: DPH) and Pagegroup…

Read more »

Investing Articles

Should you be buying AstraZeneca plc, Alliance Pharma plc and Dechra Pharmaceuticals plc today?

Are these three healthcare stocks ripe for investment? AstraZeneca plc (LON: AZN), Alliance Pharma plc (LON: APH) and Dechra Pharmaceuticals…

Read more »

Investing Articles

Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?

Royston Wild runs the rule over headline makers Dechra Pharmaceuticals plc (LON: DPH), Enquest Plc (LON: ENQ) and Cairn Energy…

Read more »

Investing Articles

Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On The Cusp Of Stunning Returns?

Could these 3 healthcare stocks transform your portfolio? GlaxoSmithKline plc (LON: GSK), Dechra Pharmaceuticals plc (LON: DPH) and CareTech Holdings…

Read more »

Investing Articles

4 Great Growth Picks For 2016 And Beyond: Barclays PLC, Dechra Pharmaceuticals plc, Britvic Plc And Marks & Spencer Group Plc

Royston Wild analyses the growth potential of Barclays PLC (LON: BARC), Dechra Pharmaceuticals plc (LON: DPH), Britvic Plc (LON: BVIC)…

Read more »

Investing Articles

Are AstraZeneca plc, Indivior PLC & Dechra Pharmaceuticals plc Set To Double by 2016?

AstraZeneca plc (LON:AZN), Indivior PLC (LON:INDV) and Dechra Pharmaceuticals plc (LON:DPH) offer three very different risk profiles, argues Alessandro Pasetti.

Read more »

Investing Articles

Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC Are A Perfect Healthcare Combination

AstraZeneca plc (LON:AZN), Dechra Pharmaceuticals plc (LON:DPH) and Tissue Regenix Group PLC (LON:TRX) are a terrific trio to buy today.

Read more »